ACA’s Reach Surges With 200,000 New Signups, More States Involved
TUESDAY, March 23, 2021 (HealthDay News) — More than 200,000 Americans signed up for health...
Read More
Hematology/Oncology
ACA’s Reach Surges With 200,000 New Signups, More States Involved
TUESDAY, March 23, 2021 (HealthDay News) — More than 200,000 Americans signed up for health...
Read More
Willingness to Get COVID-19 Vaccine Up in Health Care Workers
TUESDAY, March 23, 2021 (HealthDay News) – Health care workers may be increasingly receptive to...
Read More
Many Older Adults Unaware of Potential Side Effects for New Rx
MONDAY, March 22, 2021 (HealthDay News) — Physicians should spend more time explaining side...
Read More
Incidence of Gallbladder and Biliary Tract Cancer Up From 1990 to 2017
MONDAY, March 22, 2021 (HealthDay News) — From 1990 to 2017, the incidence of and mortality...
Read More
Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
To investigate the potential molecular mechanism of ovarian cancer (OC) evolution and...
Read More
Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients.
Recurrent ovarian cancer is an incurable disease with variable but poor prognosis. Health-related...
Read More
Socioeconomic Deprivation Linked to Worse Survival in Cancer Trials
THURSDAY, March 18, 2021 (HealthDay News) — High area-level socioeconomic deprivation is...
Read More
Life Expectancy Down for Those Without a College Degree
THURSDAY, March 18, 2021 (HealthDay News) — Between 1990 and 2018, the U.S. adult life...
Read More
COVID-19 Antibodies Found in One in Five U.S. Blood Donations
WEDNESDAY, March 17, 2021 (HealthDay News) — COVID-19 antibodies were found in the blood of...
Read More
Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know.
Poly (ADP-ribose) polymerase (PARP) inhibitors are being developed in maintenance and recurrence...
Read More
The results of multigene panel sequencing in Slovak HBOC families.
Hereditary breast and ovarian cancer (HBOC) is primarily associated with mutations in the BRCA1/2...
Read More
Non-contrast MRI can accurately characterize adnexal masses: a retrospective study.
To determine the accuracy of interpretation of a non-contrast MRI protocol in characterizing...
Read More
Immediate Start of ART for HIV May Impact 10-Year Risk for Cancer
TUESDAY, March 16, 2021 (HealthDay News) — For people with HIV, deferral of antiretroviral...
Read More
COVID-19 Impacting Caregivers of Children With Cancer
MONDAY, March 15, 2021 (HealthDay News) — Caregivers of childhood cancer survivors are...
Read More
Pooled Analysis Shows Men Have Higher Mortality Than Women
MONDAY, March 15, 2021 (HealthDay News) — Men have higher mortality than women, with...
Read More
AstraZeneca Says Its COVID-19 Vaccine Is Safe, Despite Reports of Deadly Clots
MONDAY, March 15, 2021 (HealthDay News) — There is no scientific evidence linking the...
Read More
US Breast Cancer Centers Recommend Earlier Initiation of Screening
MONDAY, March 15, 2021 (HealthDay News) — Most U.S. breast cancer centers recommend that...
Read More
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.
Targeting cell division by chemotherapy is a highly effective strategy to treat a wide range of...
Read More
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.
Y box binding protein 1 (YB-1) is a multifunctional protein associated with tumor progression and...
Read More